Nutrition, Cancer and Personalized Medicine

被引:13
作者
Ali Flores-Perez, Jose [1 ]
de la Rosa Oliva, Fabiola [2 ]
Argenes, Yacab [3 ]
Meneses-Garcia, Abelardo [3 ]
机构
[1] Nanopharm Diagnost, Lab Oncogenom, Mexico City, DF, Mexico
[2] Univ Autonoma Zacatecas, Unidad Acad Med Humana & Odontol, Mexico City, DF, Mexico
[3] Inst Nacl Cancerol, Translat Med Lab, Mexico City, DF, Mexico
来源
TRANSLATIONAL RESEARCH AND ONCO-OMICS APPLICATIONS IN THE ERA OF CANCER PERSONAL GENOMICS | 2019年 / 1168卷
关键词
Cancer; Diet; Nutrition; Precision therapy; Personalized therapy; Biomarker; Targeted therapy; Resveraterol; Lycopene; Curcumin; EGCG; GLYCATION END-PRODUCTS; BODY-COMPOSITION; TUMOR-GROWTH; GREEN TEA; OBESITY; PREVENTION; RECEPTOR; THERAPY; PHARMACOKINETICS; RESVERATROL;
D O I
10.1007/978-3-030-24100-1_11
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer is a complex group of diseases where different signaling pathways have been found to be deregulated, mainly related to cell proliferation, angiogenesis, metastasis, evasion of apoptosis and insensitivity to anti-growth sings among others. Diet plays a fundamental role in the treatment of the oncological patients, we must be aware that food can interact with certain types of cancer therapy. On the other hand, cancer therapies sometimes affect the patient's sense of smell, taste, appetite, gastric capacity or nutrient absorption, which often results in malnutrition due to the lack of essential nutriments. In this chapter we will review the effect of different metabolic disorders in cancer and mechanisms of action of some phytochemicals found in different foods like resveratrol, EGCG, curcumin and lycopene.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 54 条
  • [1] Abdelmagid SA, 2016, NUTR METAB INSIGHTS, V9, P71, DOI [10.4137/nmi.s39043, 10.4137/NMI.S39043]
  • [2] Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
  • [3] Saffron: A Potential Candidate for a Novel Anticancer Drug Against Hepatocellular Carcinoma
    Amin, Amr
    Hamza, Alaaeldin A.
    Bajbouj, Khuloud
    Ashraf, S. Salman
    Daoud, Sayel
    [J]. HEPATOLOGY, 2011, 54 (03) : 857 - 867
  • [4] Cancer cachexia: understanding the molecular basis
    Argiles, Josep M.
    Busquets, Silvia
    Stemmler, Britta
    Lopez-Soriano, Francisco J.
    [J]. NATURE REVIEWS CANCER, 2014, 14 (11) : 754 - 762
  • [5] Resveratrol: A review of preclinical studies for human cancer prevention
    Athar, Mohammad
    Back, Jung Ho
    Tang, Xmwel
    Kim, Kwang Ho
    Kopelovich, Levy
    Bickers, David R.
    Kim, Arianna L.
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (03) : 274 - 283
  • [6] Current evidence linking polyunsaturated fatty acids with cancer risk and progression
    Azrad, Maria
    Turgeon, Chelsea
    Demark-Wahnefried, Wendy
    [J]. FRONTIERS IN ONCOLOGY, 2013, 3
  • [7] Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer
    Bisht, Savita
    Mizuma, Masamichi
    Feldmann, Georg
    Ottenhof, Niki A.
    Hong, Seung-Mo
    Pramanik, Dipankar
    Chenna, Venugopal
    Karikari, Collins
    Sharma, Rajni
    Goggins, Michael G.
    Rudek, Michelle A.
    Ravi, Rajani
    Maitra, Amarnath
    Maitra, Anirban
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (08) : 2255 - 2264
  • [8] Fatty acids and breast cancer: Sensitization to treatments and prevention of metastatic re-growth
    Bougnoux, Philippe
    Hajjaji, Nawale
    Maheo, Karine
    Couet, Charles
    Chevalier, Stephan
    [J]. PROGRESS IN LIPID RESEARCH, 2010, 49 (01) : 76 - 86
  • [9] Clinical Implications of Sarcopenic Obesity in Cancer
    Carneiro, Isabella P.
    Mazurak, Vera C.
    Prado, Carla M.
    [J]. CURRENT ONCOLOGY REPORTS, 2016, 18 (10)
  • [10] Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]